UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases

Journal of clinical gastroenterology, 2022-02, Vol.56 (2), p.148

2022

Volltextzugriff (PDF)

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

The lancet. Gastroenterology & hepatology, 2022-02, Vol.7 (2), p.128-140

2022

Volltextzugriff (PDF)

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

The lancet. Gastroenterology & hepatology, 2022-02, Vol.7 (2), p.118-127

2022

Volltextzugriff (PDF)

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Gastroenterology (New York, N.Y. 1943), 2023-09, Vol.165 (3), p.670-681

2023

Volltextzugriff (PDF)

Editorial: ustekinumab during pregnancy—reassuring but still not enough. Authors' reply

Alimentary pharmacology & therapeutics, 2023-01, Vol.57 (1), p.160-160

2023

Volltextzugriff (PDF)

Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study

Alimentary pharmacology & therapeutics, 2022-11, Vol.56 (9), p.1361-1369

2022

Volltextzugriff (PDF)

Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study

The American journal of gastroenterology, 2019-07, Vol.114 (7), p.1172-1175

2019

Volltextzugriff (PDF)

Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial

The American journal of gastroenterology, 2023-02, Vol.118 (2), p.367-370

2023

Volltextzugriff (PDF)

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience

Inflammatory bowel diseases, 2017-03, Vol.23 (3), p.404-408

2017

Volltextzugriff (PDF)

Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2358183

2024

Volltextzugriff (PDF)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

Therapeutic advances in gastroenterology, 2021, Vol.14, p.17562848211053112-17562848211053112

2021

Volltextzugriff (PDF)

Probiotics and prebiotics in Crohn's disease therapies

Baillière's best practice & research. Clinical gastroenterology, 2016-02, Vol.30 (1), p.81-88

2016

Volltextzugriff (PDF)

Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center

Journal of clinical medicine, 2023-06, Vol.12 (12), p.4120

2023

Volltextzugriff (PDF)

Multidisciplinary Perinatal Care in IBD

Journal of Crohn's and colitis, 2023-05, Vol.17 (5), p.663-680

2023

Volltextzugriff (PDF)

Sa1868 ALTERATIONS IN MICROBIAL COMPOSITION IN PATIENTS WITH NEWLY DIAGNOSED CROHN'S DISEASE OVER A COURSE OF ONE YEAR: DATA FROM A PROSPECTIVE LONGITUDINAL REAL-WORLD STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-558-S-558

2024

Volltextzugriff (PDF)

115 PHOTOPLETHYSMOGRAPHY WAVEFORM ANALYSIS DETECTS INFLAMMATORY STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-32-S-33

2024

Volltextzugriff (PDF)

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.454-467

2022

Volltextzugriff (PDF)

Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience

Digestive diseases (Basel), 2023-03, Vol.41 (2), p.233-238

2023

Volltextzugriff (PDF)

Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD

Journal of Crohn's and colitis, 2024-04, Vol.18 (4), p.548-559

2024

Volltextzugriff (PDF)

DYSPLASIA DETECTION RATES IN A SURVEILLANCE PROGRAM REAL-WORLD DATA FROM A TERTIARY REFERRAL CENTER FOR INFLAMMATORY BOWEL DISEASES

Gastrointestinal endoscopy, 2023-06, Vol.97 (6), p.AB549-AB549

2023

Volltextzugriff (PDF)

Peripartum Infections Among Women With Inflammatory Bowel Disease

Inflammatory bowel diseases, 2023-07, Vol.29 (7), p.1098-1104

2023

Volltextzugriff (PDF)

Su1813 EXTERNALLY VALIDATED ARTIFICIAL INTELLIGENCE EXPLAINABLE INTERACTIVE TOOL FOR PREDICTING AND COMPARING THE DRUG SUSTAINABILITY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-825-S-826

2024

Volltextzugriff (PDF)

Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study

United European gastroenterology journal, 2020-05, Vol.8 (4), p.418-424

2020

Volltextzugriff (PDF)

Mo1557: DRUG PERSISTENCE AND ENDOSCOPIC, HISTOLOGIC AND BIOCHEMICAL REMISSION RATES AMONG PATIENTS FOLLOWING ILEAL-ANAL POUCH ANASTOMOSIS TREATED WITH BIOLOGIC THERAPY: RESULTS FROM A PROSPECTIVE PATIENT COHORT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-818-S-818

2022

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Gastroenterology & Hepatology
(29)
Humans
(24)
Inflammatory Bowel Disease
(16)
Female
(15)
Adult
(14)
Male
(12)
Crohn's Disease
(11)
Ulcerative Colitis
(10)
Inflammatory Bowel Diseases
(8)
Pregnancy
(8)
Prospective Studies
(8)
Retrospective Studies
(8)
Colitis, Ulcerative - Drug Therapy
(7)
Middle Aged
(7)
Gastroenterology
(6)
Gastroenterology And Hepatology
(6)
Inflammatory Bowel Diseases - Drug Therapy
(6)
Treatment Outcome
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Editorial: ustekinumab during pregnancy—reassuring but still not enough. Authors' reply

Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study

Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study

Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience

Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

Probiotics and prebiotics in Crohn's disease therapies

Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center

Multidisciplinary Perinatal Care in IBD

Sa1868 ALTERATIONS IN MICROBIAL COMPOSITION IN PATIENTS WITH NEWLY DIAGNOSED CROHN'S DISEASE OVER A COURSE OF ONE YEAR: DATA FROM A PROSPECTIVE LONGITUDINAL REAL-WORLD STUDY

115 PHOTOPLETHYSMOGRAPHY WAVEFORM ANALYSIS DETECTS INFLAMMATORY STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience

Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD

DYSPLASIA DETECTION RATES IN A SURVEILLANCE PROGRAM REAL-WORLD DATA FROM A TERTIARY REFERRAL CENTER FOR INFLAMMATORY BOWEL DISEASES

Peripartum Infections Among Women With Inflammatory Bowel Disease

Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]

Su1813 EXTERNALLY VALIDATED ARTIFICIAL INTELLIGENCE EXPLAINABLE INTERACTIVE TOOL FOR PREDICTING AND COMPARING THE DRUG SUSTAINABILITY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE ULCERATIVE COLITIS

Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study

Mo1557: DRUG PERSISTENCE AND ENDOSCOPIC, HISTOLOGIC AND BIOCHEMICAL REMISSION RATES AMONG PATIENTS FOLLOWING ILEAL-ANAL POUCH ANASTOMOSIS TREATED WITH BIOLOGIC THERAPY: RESULTS FROM A PROSPECTIVE PATIENT COHORT

Suchergebnisse filtern